Paper
Eriodictyol-7-O-glucoside, a novel Nrf2 activator, confers protection against cisplatin-induced toxicity.
Published Jun 1, 2012 · Qing-wen Hu, Donna D. Zhang, Limei Wang
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
51
Citations
2
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Eriodictyol-7-O-glucoside, a novel Nrf2 activator, significantly improves cell survival under cisplatin exposure, demonstrating its potential as a therapeutic approach to subvert cisplatin side effects in normal cells.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...